Full-Time
Maintenance Engineer
Zeiss
1,001-5,000 employees
Corporate venture capital for deep-tech startups
No salary listed
Bengaluru, Karnataka, India
In Person
Bachelor's
 Mechanical Engineering (1) |
|---|
Get referred to Zeiss
See people who can refer or advise you
- A Bachelor's degree or Diploma in Electrical and Electronics Engineering or Mechatronics Engineering is required.
- A minimum of 5–8 years of maintenance experience in manufacturing, industrial, or process industries is required.
- Experience in maintenance planning and troubleshooting activities is required.
- Strong knowledge of industrial machinery and maintenance systems is required.
- Expertise in preventive and predictive maintenance techniques is required.
- Understanding of CNC machines, programmable logic controllers, automation systems, and utility equipment is required.
- Experience programming and troubleshooting programmable logic controllers, including Siemens, Delta, ABB, and Beckhoff systems, is required.
- Hands-on experience with a Manufacturing Execution System is required.
- Experience with root cause analysis tools including the five whys analysis, Fishbone diagram, and DMAIC is required.
- Familiarity with computerized maintenance management system software such as SAP, other local computerized maintenance management systems, and Power Apps is required.
- Knowledge of safety and quality standards is required.
- The role requires the ability to work shifts and provide emergency breakdown support as needed.
- Experience with Power BI, advanced Excel, PowerPoint presentations, and two-dimensional computer-aided design is required.
- Knowledge of the local language is required.
- Plan and execute preventive, predictive, and corrective maintenance activities.
- Ensure maximum availability and reliability of machinery and equipment.
- Analyze equipment breakdowns using quality tools and implement corrective and preventive actions.
- Prioritize breakdowns and attend to them accordingly.
- Improve the overall performance of machines.
- Implement total productive maintenance and drive the total productive maintenance culture in the organization.
- Plan and delegate responsibilities to technicians when needed and ensure results are delivered.
- Review spare parts inventory, define critical spare parts, and maintain inventory levels.
- Develop a troubleshooting catalogue for each production machine.
- Drive continual improvements for the department and lead improvement projects.
- Optimize layouts for improved efficiency and machine cycle time using lean concepts.
- Develop a skill matrix, identify team skill gaps, and ensure required training is provided.
- Diagnose mechanical, electrical, hydraulic, and pneumatic issues.
- Lead troubleshooting activities during equipment breakdowns.
- Support root cause analysis and failure analysis.
- Restore equipment quickly to minimize downtime.
- Assist with installation, commissioning, and testing of new equipment.
- Meet department key performance indicators, including mean time to repair, mean time between failures, and preventive-maintenance adherence.
- Supervise maintenance technicians and junior engineers.
- Allocate maintenance tasks and monitor work completion.
- Provide technical guidance and on-the-job training to maintenance staff.
- Ensure adherence to maintenance procedures and best practices.
- Ensure maintenance activities comply with safety regulations and company standards.
- Conduct safety inspections and risk assessments.
- Ensure lockout/tagout procedures, safety standards, and personal protective equipment requirements are followed by the team.
- Maintain maintenance documentation and reports.
- Ensure compliance with statutory and environmental regulations.
- Monitor spare parts consumption and inventory levels.
- Coordinate with procurement to ensure timely availability of spare parts and consumables.
- Evaluate vendors and maintenance service providers.
- Identify opportunities for cost reduction and efficiency improvement.
- Support total productive maintenance, lean manufacturing, and continuous improvement initiatives.
- Recommend equipment upgrades and process improvements.
- Participate in energy-saving and reliability-improvement projects.
- Experience in total productive maintenance, lean manufacturing, Six Sigma, or reliability engineering.
- Certification in maintenance or safety management.
- Experience with SAP Plant Maintenance or similar maintenance systems.
- Experience preparing standard operating procedures, standard work instructions, and ISO documents.
ZEISS Ventures is the corporate venture capital arm of the ZEISS Group, investing in deep-tech startups in Information Technology, Industrial Tech, MedTech, and Life Sciences. It backs early-stage companies at pre-Series A to Series A with typical investments of $1–5 million. The fund provides capital and tailored funding solutions, leveraging ZEISS’s global network and optics/optoelectronics expertise to support portfolio companies. Its goal is to accelerate the development of new technologies and business models that complement ZEISS’s portfolio while actively engaging with external innovation.
Company Size
1,001-5,000
Company Stage
Growth Equity (Non-Venture Capital)
Total Funding
$67.7M
Headquarters
Oberkochen, Germany
Founded
2001
Get referred to Zeiss
See people who can refer or advise you
Simplify's Take
What believers are saying
- ZEISS Ventures led SeeTrue's €2.2 million round on 2026-08-05, reinforcing eye-tracking leadership.
- ZEISS backed Maculaser and Custom Surgical in 2026, deepening ophthalmology innovation pipelines.
- ZEISS launched Otus ML 1.4/35, Panoptes 65, and DuraVision Plus in 2026.
What critics are saying
- ZEISS Meditec plans up to 1,000 job cuts through 2028/29 after 5.7% revenue decline.
- ProfitUp requires over €150m restructuring costs, signaling weak margins and execution strain.
- If ophthalmology turnaround fails, ZEISS Meditec drags group cash flow and venture appetite.
What makes Zeiss unique
- ZEISS Ventures backs deep-tech tied to ZEISS optics, medtech, and industrial workflows.
- ZEISS brings distribution, engineering, and clinical validation to early startups like Custom Surgical.
- ZEISS spans lenses, microscopy, and eye care, creating cross-selling across adjacent markets.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Paid Vacation
Performance Bonus
Company News
ZEISS Medical Technology has launched a cataract-only configuration of its DORC EVA NEXUS ophthalmic surgical system. The system features a cataract grade selection with up to four programmable presets, allowing surgeons to optimise phaco, aspiration, and irrigation settings for each surgical step. The solution includes VacuFlow VTi pump, SMART IOP, and EVA EQUIPHACO technologies, designed to provide streamlined performance, stability, and control during procedures. It integrates with the ZEISS Cataract Workflow portfolio. The system debuted at the European Society of Cataract and Refractive Surgeons congress in London. It will become available in select European countries from September 2026, with global rollout pending regulatory approvals. The technology expands ZEISS's existing EVA NEXUS platform, which previously focused on retina workflows.
ZEISS Medical Technology announced FDA 510(k) clearance for ZEISS CLINIC 360, a cloud-based software solution that aggregates ophthalmic clinical data and provides advanced analytics. The browser-based platform combines diagnostic and medical data into a comprehensive patient view, helping clinicians evaluate disease progression and support treatment decisions. The solution integrates data from DICOM-enabled diagnostic devices, including ZEISS's CIRRUS, CLARUS and HFA systems, as well as third-party devices. It features disease-based summaries, interactive analysis tools, and collaboration capabilities through ZEISS Collaborative Care. ZEISS CLINIC 360 will be available in the US in early autumn 2026 on a subscription basis with low upfront costs. The platform complements ZEISS FORUM, the company's on-premise data management system, giving providers flexibility in choosing their preferred infrastructure approach.
ZEISS Ventures led a €2.2 million investment round in SeeTrue Technologies, a Finnish deep-tech company developing miniaturised eye-tracking technology. The funding will accelerate commercialisation of SeeTrue's ultra-low-power eye-sensing architecture for next-generation interfaces in smart optical systems and eyewear. SeeTrue's proprietary technology combines miniaturised sensing hardware with optimised embedded processing, enabling scalable eye-sensing capabilities with low power consumption and small hardware footprint. The technology supports gaze-based interaction and attention-aware computing across healthcare, industrial, and smart eyewear applications. The investment round includes participation from Superhero Capital and North Karelia Growth Fund, managed by Redstone Nordics. Founded in 2018 and based in Joensuu, Finland, SeeTrue develops ultra-miniature eye-tracking technology for medical optical systems, vision care, and smart wearables.
ZEISS Medical Technology has announced successful early clinical implantations of its AT LUCIA toric 721P intraocular lens, designed to treat cataracts whilst correcting astigmatism. The company is conducting an early-access clinical trial with experienced surgeons across six European countries. The lens combines an aspheric bitoric optic with a patented non-constant aberration design on a fully preloaded, hydrophobic platform. Surgeons have reported positive early impressions, highlighting the lens's precision, stability and surgical handling. Currently CE marked, the AT LUCIA toric 721P will be showcased at the International Congress of German Ophthalmic Surgery in Nuremberg from 18–20 June 2026. The lens is expected to be commercially available in select European countries later this year.
ZEISS Ventures has invested in Maculaser, a Finnish medtech company developing temperature-controlled retinal laser therapy, through a funding round co-led with M2care. The investment will support clinical development of the company's personalized treatment for retinal diseases. Founded in 2020 and based on research from Aalto University, Maculaser has developed patented technology that provides real-time temperature control during laser treatment. The non-damaging approach activates natural cellular defence mechanisms, targeting affected retinal areas early to delay or prevent progression of age-related macular degeneration and diabetic maculopathy. The technology aims to shift retinal care from managing late-stage damage to proactive vision preservation, offering an outpatient procedure that integrates into regular eye care. Maculaser plans to bring the treatment into clinical practice to benefit millions of patients worldwide.